Statin myopathy: risk factors
Written and reviewed by Dr Ibrahim Imam, Consultant Neurologist. Last reviewed .
Statin myopathy: risk factors. Cerivastatin: this has the highest risk, Simvastatin, Atorvastatin, Lovastatin. Fully referenced neurology checklist.
High risk statins: lipophilic statins
- Cerivastatin: this has the highest risk
- Simvastatin
- Atorvastatin
- Lovastatin
Low risk statins: hydrophilic statins
Locked: subscribe to see this section.
Subject-related risk factors
Locked: subscribe to see this section.
Possible genetic risk factors
Locked: subscribe to see this section.
Co-morbid disease risk factors
Locked: subscribe to see this section.
Drug-related risk factors
Locked: subscribe to see this section.
Autoimmune risk factors
Locked: subscribe to see this section.
Dietary risk factors
Locked: subscribe to see this section.
References
- Sathasivam S, Lecky B. Statin induced myopathy. BMJ 2008; 337:a2286.
- Sewright KA, Clarkson PM, Thompson PD. Statin myopathy: incidence, risk factors, pathophysiology. Curr Atheroscler Rep 2007; 9:389-396.
- Fernandez G, Spatz ES, Jablecki C, Phillips PS. Statin myopathy: a common dilemma not reflected in clinical trials. Cleve Clinic J Med 2011; 78:393-503.
- Tsushima Y, Hatipoglu B. Statin intolerance: a review and update. Endocr Pract 2023; 29:566-571.
- Graham DJ, Staffs JA, Shatin D, et al. Incidence of hospitalized rhabdomyolysis in patients treated with lipid lowering drugs. JAMA 2004; 292:2585-2590.
- And 4 more. Subscribe to see the full list
